he FTSE 100 was set for a sluggish session today despite tech shares in the US hitting yet more records overnight.
European stock markets were expected to take more note of the traditional US stocks which, unlike their tech counterparts, slipped back on Tuesday, led by concerns over Johnson & Johnson’s Covid vaccine.
The drugs giant headed into reverse after its one-shot jab was suspended in the US over concerns about rare blood clots similar to those experienced by a small number of AstraZeneca vaccine receivers.
The news unsettled markets somewhat and led to a delay for European rollout of the jab. That alarmed economists who have seen it as part of the solution to the covid crisis still gripping parts of the EU. Shares in Moderna and BioNTech jumped last night as J&J fell.
AstraZeneca’s shares will be under scrutiny in trading today as its jab, like J&J’s is a modified adenovirus.
The FTSE 100 was expected to open up 2.2 points at 6895.3 according to prices being quoted on the IG platform.
The lsluggish performances of shares came despite a sharp fall in US bond…